Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elvira De Martino is active.

Publication


Featured researches published by Elvira De Martino.


Clinical Endocrinology | 2005

Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine‐needle aspiration cytology?

Carlo Cappelli; Ilenia Pirola; D. Cumetti; Linda Micheletti; Andrea Tironi; Elena Gandossi; Elvira De Martino; Laura Cherubini; Barbara Agosti; Maurizio Castellano; Chiara Mattanza; E. Agabiti Rosei

Background  As a consequence of the increasing application of ultrasound (US) technology, the detection of asymptomatic nonpalpable thyroid nodules has generally increased. The aim of our study was to assess if the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules (A/T) ≥ 1 could be a sonographic criterion for recommending fine‐needle aspiration cytology (FNAC).


Diabetes Care | 2009

TSH-Lowering Effect of Metformin in Type 2 Diabetic Patients: Differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients

Carlo Cappelli; Mario Rotondi; Ilenia Pirola; Barbara Agosti; Elena Gandossi; Umberto Valentini; Elvira De Martino; Antonio Cimino; Luca Chiovato; Maurizio Castellano

OBJECTIVE To assess the interplay between metformin treatment and thyroid function in type 2 diabetic patients. RESEARCH DESIGN AND METHODS The acute and long-term effects of metformin on thyroid axis hormones were assessed in diabetic patients with primary hypothyroidism who were either untreated or treated with levothyroxine (L-T4), as well as in diabetic patients with normal thyroid function. RESULTS No acute changes were found in 11 patients with treated hypothyroidism. After 1 year of metformin administration, a significant thyrotropin (TSH) decrease (P < 0.001) was observed in diabetic subjects with hypothyroidism who were either treated (n = 29; from 2.37 ± 1.17 to 1.41 ± 1.21 mIU/l) or untreated (n = 18; 4.5 ± 0.37 vs. 2.93 ± 1.48) with L-T4, but not in 54 euthyroid subjects. No significant change in free T4 (FT4) was observed in any group. CONCLUSIONS Metformin administration influences TSH without change of FT4 in patients with type 2 diabetes and concomitant hypothyroidism. The need for reevaluation of thyroid function in these patients within 6–12 months after starting metformin is indicated.


Clinical Endocrinology | 2008

Reduced thyroid volume and nodularity in dyslipidaemic patients on statin treatment

Carlo Cappelli; Maurizio Castellano; Ilenia Pirola; Elvira De Martino; Elena Gandossi; Andrea Delbarba; Andrea Salvi; Enrico Agabiti Rosei

Background  Little information is available concerning the possible antiproliferative effects of 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG‐CoA) reductase inhibitors (statins) on the thyroid gland. We have hypothesized that the antiproliferative effects of statins observed in thyroid cell lines in vitro may have a clinical counterpart that could be detected by investigating the prevalence and size of thyroid nodules in patients on long‐term treatment with statins.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2013

Thyroglobulin measurement in fine-needle aspiration biopsy of metastatic lymph nodes after rhTSH stimulation

Carlo Cappelli; Ilenia Pirola; Elvira De Martino; Elena Gandossi; Elena Cimino; Francesca Samoni; Barbara Agosti; Enrico Agabiti Rosei; Claudio Casella; Maurizio Castellano

Thyroglobulin measurement in the washout of the needle used in fine‐needle aspiration cytology (FNAC) has been proposed for the early detection of lymph node metastasis both in patients with or without serum thyroglobulin antibodies; however, up to now, there have been no reports that recombinant human thyrotropin (rhTSH) stimulation modifies thyroglobulin measurement in lymph node aspirates.


European Journal of Endocrinology | 2006

Thyroid nodule shape suggests malignancy

Carlo Cappelli; Maurizio Castellano; Ilenia Pirola; Elena Gandossi; Elvira De Martino; D. Cumetti; Barbara Agosti; Enrico Agabiti Rosei


Endocrine Journal | 2007

Prognostic Value of Thyrotropin Receptor Antibodies (TRAb) in Graves' Disease: A 120 Months Prospective Study

Carlo Cappelli; Elena Gandossi; Maurizio Castellano; Claudio Pizzocaro; Barbara Agosti; Andrea Delbarba; Ilenia Pirola; Elvira De Martino; Enrico Agabiti Rosei


Surgery Today | 2006

Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy.

Carlo Cappelli; M. Braga; Elvira De Martino; Maurizio Castellano; Elena Gandossi; Barbara Agosti; D. Cumetti; Ilenia Pirola; Chiara Mattanza; Laura Cherubini; Enrico Agabiti Rosei


Endocrine Journal | 2008

Aggressive Thyroid Carcinoma Showing Thymic-Like Differentiation (Castle) : Case Report and Review of the Literature

Carlo Cappelli; Andrea Tironi; Gian Pietro Marchetti; Ilenia Pirola; Elvira De Martino; Andrea Delbarba; Maurizio Castellano; Enrico Agabiti Rosei


Obesity Surgery | 2012

Morbid Obesity in Women is Associated to a Lower Prevalence of Thyroid Nodules

Carlo Cappelli; Ilenia Pirola; Francesco Mittempergher; Elvira De Martino; Claudio Casella; Barbara Agosti; Riccardo Nascimbeni; Annamaria Formenti; Enrico Agabiti Rosei; Maurizio Castellano


Endocrine Journal | 2004

Long-term Treatment of Acromegaly with Lanreotide: Evidence of Increased Serum Parathormone Concentration

Carlo Cappelli; Elena Gandossi; Barbara Agosti; Bruno Cerudelli; D. Cumetti; Maurizio Castellano; Ilenia Pirola; Elvira De Martino; Enrico Agabiti Rosei

Collaboration


Dive into the Elvira De Martino's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge